Back to search
Hypertriglyceridemic Acute Pancreatitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypertriglyceridemic Acute Pancreatitis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypertriglyceridemic Acute Pancreatitis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has become the second most common cause of acute pancreatitis in China, accounting for u…
The study will evaluate safety and tolerance of intravenous delivery of GC304 gene therapy drug as a treatment of primary hypertriglyceridemic patients with pre…
Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is associated with a high risk of recurrence despite standard lipid-lowering therapy and lifestyle modi…
To compare effectiveness in reducing triglycerides between daily plasma exchange and glucose+insulin infusion in patients with non-severe acute hypertriglycerid…